The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bicycle Therapeutics Plc ADR shares valued at $5,780 were sold by Hannay Michael Charles Ferguso on Apr 11 ’24. At $22.49 per share, Hannay Michael Charles Ferguso sold 257 shares. The insider’s holdings dropped to 22,891 shares worth approximately $0.5 million following the completion of this transaction.
Also, Lee Kevin sold 3,158 shares, netting a total of over 75,192 in proceeds. Following the sale of shares at $23.81 each, the insider now holds 387,270 shares.
Before that, Crockett Nigel had sold 955 shares from its account. In a trade valued at $22,739, the CHIEF BUSINESS OFFICER traded Bicycle Therapeutics Plc ADR shares for $23.81 each. Upon closing the transaction, the insider’s holdings decreased to 955 shares, worth approximately $1.04 million.
As published in a research note from B. Riley Securities on September 11, 2023, Bicycle Therapeutics Plc ADR [BCYC] has been rated up from a Neutral to a Buy. Analysts at Cowen started covering the stock with ‘”an Outperform”‘ outlook in a report released in late August. As of July 28, 2022, Barclays has initiated its “an Overweight” rating for BCYC.
Analyzing BCYC Stock Performance
During the last five days, there has been a drop of approximately -5.09%. Over the course of the year, Bicycle Therapeutics Plc ADR shares have jumped approximately 20.69%. Shares of the company reached a 52-week high of $27.24 on 02/28/24 and a 52-week low of $16.13 on 01/05/24. A 50-day SMA is recorded $23.25, while a 200-day SMA reached $20.37. Nevertheless, trading volume fell to 0.47 million shares from 0.25 million shares the previous day.
Support And Resistance Levels for Bicycle Therapeutics Plc ADR (BCYC)
According to the 24-hour chart, there is a support level at 21.35, which, if violated, would cause prices to drop to 20.88. In the upper region, resistance lies at 22.64. The next price resistance is at 23.47. RSI (Relative Strength Index) is 37.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.07, which suggests the price will decrease in the coming days. Percent R is at 93.96%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
